QSAR multi-target in drug discovery: A review

Current Computer-Aided Drug Design

Volumn 10, Issue 2, 2014, Pages 129-136

  Zanni, Riccardo ^a   Gálvez Llompart, María ^a   Gálvez, Jorge ^a   García Domenech, Ramón ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Anaerobic bacteria; Molecular topology; Multi target QSAR

Indexed keywords

COMPUTATIONAL CHEMISTRY; MOLECULAR GRAPHICS;

ANAEROBIC BACTERIUM; DRUG DISCOVERY; MOLECULAR TOPOLOGIES; MULTI-TARGET QSAR; MULTI-TARGETS; MULTIPLE OUTPUTS; QSAR MODEL; RESEARCH GROUPS; SIMPLE++; SINGLE EQUATION;

BACTERIA;

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; BIAPENEM; CEFOPERAZONE; CEFOTETAN; CEFOXITIN; CEFTIZOXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINAFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; FLEROXACIN; IMIPENEM; LEVOFLOXACIN; LOMEFLOXACIN; MEROPENEM; METRONIDAZOLE; MINOCYCLINE; OFLOXACIN; PIPERACILLIN; ROXITHROMYCIN; SITAFLOXACIN; SPARFLOXACIN; TETRACYCLINE; TROVAFLOXACIN; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; ARTIFICIAL NEURAL NETWORK; CLASSIFICATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; DISCRIMINANT ANALYSIS; DRUG RESEARCH; MOLECULAR MODEL; PEPTOSTREPTOCOCCUS; PHARMACOLOGICAL PROCEDURES; PREDICTION; PREVOTELLA; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; ALGORITHM; ANIMAL; DRUG DEVELOPMENT; HUMAN; MOLECULARLY TARGETED THERAPY; PROBABILITY; PROCEDURES;

ALGORITHMS; ANIMALS; DRUG DISCOVERY; HUMANS; MOLECULAR TARGETED THERAPY; PROBABILITY; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84904733491     PISSN: 15734099     EISSN: 18756697     Source Type: Journal    
DOI: 10.2174/157340991002140708105124     Document Type: Review

References (44)

1. Jitender, K. M.; Himesh, S.; Singhai, A. K.; Harish P. QSAR-application in drug design. Int. J. Pharm. Res. Allied Sci., 2013, 2, 1-13.
2. Garcia-Domench, R.; Galvez-Llompart, M.; Zanni, R.; Recio, M. C.; Galvez, J. QSAR methods for the discovery of new inflammatory bowel disease drugs. Expert Opin. Drug Discov., 2013, 8, 933-949.
3. Prado-Prado, F. J.; Gonzalez-Diaz, H.; Santana, L.; Uriarte, E. Unified QSAR approach to antimicrobials. Part 2: Predicting activity against more than 90 different species in order to halt antibacterial resistance. Bioorg. Med. Chem., 2007, 15, 897-902.
4. Prado-Prado, F. J.; Borges, F.; Perez-Montoto, L. G.; Gonzalez-Diaz, H. Multi-target spectral moment: QSAR for antifungal drugs vs different fungi species. Eur. J. Med. Chem., 2009, 44, 4051-6.
5. Gutman, I.; Furtula, B. (Editors) Novel molecular structure descriptors-Theory and applications I & II, MCM Kragujevac, 2010.
6. Putz, M. V.; Ionaşcu, C.; Putz, A. M.; Ostafe, V. Alert-QSAR. Implications for Electrophilic Theory of Chemical Carcinogenesis. Int. J. Mol. Sci., 2011, 12, 5098-5134.
7. Garcia-Domenech, R.; Galvez, J.; de Julian-Ortiz, J. V.; Pogliani, L. Some new trends in chemical graph theory. Chem. Rev., 2008, 108, 1127-1169.
8. Devillers, J.; Balaban, A. T. (Editors), Topological Indices and Related Descriptors in QSAR and QSPR, Gordon and Breach Scientific Publishers: Amsterdam. 1999.
9. Castro, E. A. (Editor) QSPR-QSAR Studies on Desired Properties for Drug Design. 3. Molecular topology in QSAR and drug design studies (Galvez, J. and Garcia-Domenech, R.) Research Signpost, Kerala, India. p. 63-94, 2010.
10. Gonzalez-Diaz, H.; Sanchez, I. H.; Uriarte, E.; Santana, L. Symmetry consideration in Markovian chemicals 'in silico' design (MARCH-INSIDE) I: central chirality codification, classification of ACE inhibitors and prediction of sigma-receptor antagonist activity. Comput. Biol. Chem., 2003, 27, 217-227.
11. Galvez, J.; Galvez-Llompart, M.; Garcia-Domenech, R. Molecular topology as a novel approach for drug discovery. Expert Opin. Drug Discov., 2012, 7, 133-153.
12. Gonzalez-Diaz, H.; Prado-Prado, F. J.; Santana, L.; Uriarte, E. Unify QSAR approach to antimicrobials. Part 1: predicting antifungal activity against different species. Bioorg. Med. Chem., 2006, 14, 5973-5980.
13. Speck-Planche, A.; Kleandrova, V. V.; Luan, F.; Cordeiro, M. N. Multi-target drug discovery in anti-cancer therapy: fragment-based approach toward the design of potent and versatile anti-prostate cancer agents. Bioorg. Med. Chem., 2011, 19, 6239-6244.
14. Prado-Prado, F. J.; Gonzalez-Diaz, H.; de la Vega, O. M.; Ubeira, F. M.; Chou, K. C. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds. Bioorg. Med. Chem., 2008, 16, 5871-80.
15. Gonzalez-Diaz, H.; Duardo-Sanchez, A.; Ubeira, F. M.; Prado-Prado, F.; Perez-Montoto, L. G.; Concu, R.; Podda, G.; Shen, B. Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers. Curr. Drug Metab., 2010, 11, 379-406.
16. Estrada, E. Spectral Moments of the Edge-Adjacency Matrix of Molecular Graphs. 2. Molecules Containing Heteroatoms and QSAR Applications. J. Chem. Inf. Comput. Sci., 1997, 37, 320-328.
17. Speck-Planche, A.; Kleandrova, V. V.; Cordeiro, M. N. New insights toward the discovery of antibacterial agents: Multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs. Eur. J. Pharm. Sci., 2013, 48, 812-818.
18. Tenorio-Borroto, E.; Peñuelas Rivas, C. G.; Vásquez Chagoyán, J. C.; Castañedo, N.; Prado-Prado, F. J.; García-Mera, G.; González-Díaz, H. ANN multiplexing model of drugs effect on macrophages; theoretical and flow cytometry study on the cytotoxicity of the antimicrobial drug G1 in spleen. Bioorg. Med. Chem., 2012, 20, 6181-6194.
19. Liu, Q.; Che, D.; Huang, Q.; Cao, Z.; Zhu, R. Multi-target QSAR study in the analysis and design of HIV-1 inhibitors. Chin. J. Chem., 2010, 28, 1587-1592.
20. Liu, Q.; Zhou, H.; Liu, L.; Chen, X.; Zhu, R.; Cao, Z. Multi-target QSAR modelling in the analysis and design of HIV-HCV coinhibitors: an in-silico study. BMC Bioinformatics, 2011, 12, 294-314.
21. Garcia, I.; Fall, Y.; Gomez, G.; Gonzalez-Diaz, H. First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines. Mol. Divers., 2011, 15, 561-567.
22. Garcia, I.; Fall, Y.; Gomez, G. Using topological indices to predict anti-alzheimer and anti-parasitic GSK-3 inhibitors by multi-target QSAR in silico screening. Molecules, 2010, 15, 5408-5422.
23. Prado-Prado, F. J.; Uriarte, E.; Borges, F.; Gonzalez-Diaz, H. Multitarget spectral moments for QSAR and complex networks study of antibacterial drugs. Eur. J. Med. Chem., 2009, 44, 4516-4521.
24. Munteanu, C. R.; Magalhaes, A. L.; Uriarte, E.; Gonzalez-Diaz, H. Multi-target QPDR classification model for human breast and colon cancer-related proteins using star graph topological indices. J. Theor. Biol., 2009, 257, 303-311.
25. Prado-Prado, F. J.; Borges, F.; Uriarte, E.; Perez-Montoto, L. G.; Gonzalez-Diaz, H. Multi-target spectral moment: QSAR for antiviral drugs vs different viral species. Anal. Chim. Acta, 2009, 651, 159-164.
26. Prado-Prado, F. J.; Martinez de la Vega, O.; Uriarte, E.; Ubeira, F. M.; Chou, K. C.; Gonzalez-Diaz, H. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorg. Med. Chem., 2009, 17, 569-575.
27. Prado-Prado, F. J.; Garcia-Mera, X.; Gonzalez-Diaz, H. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorg. Med. Chem., 2010, 18, 2225-2231.
28. Prado-Prado, F. J.; Gonzalez-Diaz, H. In: Multi-target QSAR of antiviral drugs. Gonzalez-Diaz, H.; Munteanu, C. R., Ed.; Transworld Research Network: Kerala, 2010; pp. 1-14.
29. Prado-Prado, F. J.; Garcia, I.; Garcia-Mera, X.; Gonzalez-Diaz, H. Entropy multi-target QSAR model for prediction of antiviral drug complex networks. Chemometrics Intell. Lab. System, 2011, 107, 227-233.
30. Marzaro, G.; Chilin, A.; Guiotto, A.; Uriarte, E.; Brun, P.; Castagliuolo, I.; Tonus, F.; Gonzalez-Diaz, H. Using the TOPSMODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors. Eur. J. Med. Chem., 2011, 46, 2185-2192.
31. Speck-Planche, A.; Kleandrova, V. V.; Luan, F.; Cordeiro, M. N. Rational drug design for anti-cancer chemotherapy: Multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents. Bioorg. Med. Chem., 2012, 20, 4848-4855.
32. Speck-Planche, A.; Kleandrova, V. V.; Luan, F.; Cordeiro, M. N. Multi-target QSAR model for the in silico discovery of anti-breast cancer agents. Eur. J. Pharm. Sci., 2012, 47, 273-279.
33. Speck-Planche, A.; Kleandrova, V. V.; Luan, F.; Cordeiro, M. N. Fragment-based approach for the in silico discovery of multi-target insecticides. Mol. Biosyst., 2012, 8, 2188-2196.
34. Speck-Planche, A.; Kleandrova, V. V. In silico design of multitarget inhibitors for C-C chemokine receptors using substructural descriptors. Mol. Divers., 2012, 16, 183-191.
35. Speck-Planche, A.; Kleandrova, V. V.; Luan, F.; Cordeiro, M. N. A ligand-based approach for the in silico discovery of multi-target inhibitors for proteins associated with HIV infection. Mol. Biosyst., 2012, 8, 2188-2196.
36. Brook, I. In: Antimicrobial Drug Resistance; Ed.; Douglas, L.; Mayers, M. D., 2009; pp. 873-899. doi: 10. 1007/978-1-60327-595-8-15.
37. Galvez-Llompart, M.; Galvez, J.; Garcia-Domenech, R.; Kier, L. B. Modeling drug-induced anorexia by Molecular Topology. J. Chem. Inf. Model., 2012, 52, 1337-1344.
38. Kier, L. B.; Hall, L. H. Molecular Connectivity in Structure-Activity Analysis, ed.; Research Studies Press: Letchworth, UK, 1986.
39. Galvez, J.; Garcia-Domenech, R.; Salabert, M. T.; Soler, R. Charge indexes. New topological descriptors. J. Chem. Information Computer Sci., 1994, 34, 520-525.
40. Galvez, J.; Garcia-Domenech, R.; de Julian-Ortiz, J. V.; Soler, R. Topological approach to drug design. J. Chem. Inf. Comp. Sci., 1995, 35, 272.
41. DESmol1 software. Molecular Connectivity and Drug Design Research Unit. Department of Physical Chemistry. Faculty of Pharmacy. University of Valencia, 2000.
42. Statistica (data analysis software system), version 9. 0; StatSoft, I: Tulsa, OK, USA, 2009.
43. Roy, K.; Pratim Roy, P. Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques. Eur. J. Med. Chem., 2009, 44, 2913-2922.
44. Devillers, J. In: Strengths and weaknesses of the back propagation neural network in QSAR and QSPR studies; Devillers, J, Ed.; Genetic Algorithms in Molecular Modeling. Academic Press: San Diego, CA, 1996; Vol. pp. 1-24.